Lipocine Net Borrowings from 2010 to 2025

LPCN Stock  USD 3.07  0.09  2.85%   
Lipocine Net Borrowings yearly trend continues to be very stable with very little volatility. Net Borrowings is likely to grow to about -2 M this year. Net Borrowings is the difference between the amount of new debt Lipocine has taken on and the amount of debt it has paid off during a given period. View All Fundamentals
 
Net Borrowings  
First Reported
2015-12-31
Previous Quarter
-833.3 K
Current Value
-1.5 M
Quarterly Volatility
4.9 M
 
Yuan Drop
 
Covid
Check Lipocine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lipocine's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 5.8 M or Other Operating Expenses of 14.9 M, as well as many indicators such as Dividend Yield of 0.0, Ptb Ratio of 0.68 or Book Value Per Share of 4.22. Lipocine financial statements analysis is a perfect complement when working with Lipocine Valuation or Volatility modules.
  
Check out the analysis of Lipocine Correlation against competitors.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.

Latest Lipocine's Net Borrowings Growth Pattern

Below is the plot of the Net Borrowings of Lipocine over the last few years. It is the difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period. Lipocine's Net Borrowings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lipocine's overall financial position and show how it may be relating to other accounts over time.
Net Borrowings10 Years Trend
Slightly volatile
   Net Borrowings   
       Timeline  

Lipocine Net Borrowings Regression Statistics

Arithmetic Mean4,575,070
Coefficient Of Variation139.20
Mean Deviation6,103,046
Median10,000,000
Standard Deviation6,368,570
Sample Variance40.6T
Range13.3M
R-Value(0.85)
Mean Square Error12T
R-Squared0.72
Significance0.00003
Slope(1,137,718)
Total Sum of Squares608.4T

Lipocine Net Borrowings History

2025-2 M
2024-2.1 M
2022-2.3 M
2021-3.3 M
2020-1.4 M
2019-3.3 M

About Lipocine Financial Statements

Lipocine investors utilize fundamental indicators, such as Net Borrowings, to predict how Lipocine Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Borrowings-2.1 M-2 M
When determining whether Lipocine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lipocine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lipocine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lipocine Stock:
Check out the analysis of Lipocine Correlation against competitors.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.75)
Revenue Per Share
1.486
Quarterly Revenue Growth
137.519
Return On Assets
(0.15)
Return On Equity
(0.20)
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.